Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: Associated health gains and harm reductions

Medical Journal of Australia

Volumn 168, Issue 12, 1998, Pages 596-600

  Metrebian, Nicky ^a   Shanahan, William ^b   Wells, Brian ^b   Stimson, Gerry V ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b Riverside Mental Hlth Trust S   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE;

ADJUSTMENT; ADULT; ARTICLE; CRIMINAL BEHAVIOR; FEMALE; HEALTH STATUS; HUMAN; INTRAVENOUS DRUG ABUSE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METHADONE TREATMENT; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PRESCRIPTION; SELF REPORT; SOCIAL INTERACTION; TIME; UNITED KINGDOM; URINALYSIS;

EID: 0032526654     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb141444.x     Document Type: Article

References (24)

1. Farrell M, Ward J, Mattick R, et al. Methadone main tenance treatment in opiate dependence: a review. BMJ 1994; 309: 997-1001.
2. Strang J, Gossop M, editors. Heroin addiction and drug policy: the British system. Oxford: Oxford Medical Publications, 1994.
3. Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ 1996; 313: 270-272.
4. Strang J, Sheridan J. Heroin prescribing in the "British System" of the mid 1990s: data from the 1995 national survey of community pharmacies in England and Wales. Drug Alcohol Rev 1997; 16: 7-16.
5. Sell L, Farrell M, Robson P. Prescription of diamorphine, dipipanane and cocaine in England and Wales. Drug Alcohol Rev 1997; 16: 221-226.
6. Uchtenhagen A. Summary of the synthesis report. In: Uchtenhagen A, Gutzwiller F, Dobler-Mikola A, editors. Programme for a medical prescription of narcotics: final report of the research representatives. Zurich: Institute for Social and Preventive Medicine, University of Zurich, 1997.
7. Bammer G. Should the controlled provision of heroin be a treatment option? Australian feasibility considerations. Addiction 1993; 83: 467-475.
8. Metrebian N, Shanahan W, Stimson GV. Heroin prescribing in the UK: an overview. Eur Addict Res 1996; 2: 194-200.
9. Hartnoll RL, Mitcheson MC, Battersby A, et al. Evaluation of heroin maintenance in controlled trial. Arch Gen Psych 1980; 37: 877-883.
10. Battersby M, Farrell M, Gossop M, et al. "Horse trading": prescribing injectable opiates to opiate addicts. A descriptive study. Drug Alcohol Rev 1992; 11: 35-42.
11. McCusker C, Davis M. Prescribing drug of choice to illicit heroin users: the experience of a UK Community Drug Team. J Subst Abuse Treat 1996; 13; 6: 521-531.
12. Stimson GV, Oppenheimer E. Heroin addiction treatment and control in Britain. London: Tavistock Publications, 1982; 229-252.
13. Darke S, Hall W, Wodak A, et al. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users: the Opiate Treatment Index. Br J Addict 1992; 87: 733-742.
14. Adelekan M, Green A, DasGupta N, et al. Reliability and validity of the Opiate Treatment Index among a sample of opioid users in the United Kingdom. Drug Alcohol Rev 1996; 15: 261-270.
15. Overall JE, Gorham DR. The brief psychiatric rating scale. Psych Rep 1962; 10: 799-812.
16. The Task Force to Review Services for Drug Misusers. Report of an independent review of drug treatment services in England. London: Department of Health, 1996; 61-64.
17. Marks J. Who killed the British System? Druglink 1995; 10: 21.
18. Strang J, Farrell M. Treatment of heroin users [letter]. BMJ 1994; 308: 718.
19. Farrell M, Hall W. The Swiss heroin trials: testing alternative approaches [letter]. BMJ 1998; 316: 639.
20. Uchtenhagen A, Dobler-Mikola A, Gutzwiller F. Medical prescription of narcotics. Eur Addict Res 1996; 2: 201-207.
21. Gossop M, Marsden J, Stewart D, et al. The National Treatment Outcome Research Study in the United Kingdom: six month follow-up outcomes. Psych Addict Behav 1997; 11: 324-337.
22. Beckett D. Prescription of controlled drugs to addicts. BMJ 1983; 287: 127.
23. Connell PH. Drug dependence in Great Britain: a challenge to the practice of medicine. In: Steinberg, editor. Scientific basis of drug dependence. London: Churchill Livingstone, 1969.
24. Marks J. Opium the religion of the people. Lancet 1985; i: 1439-1440.